Loading…
Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity
Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (ND...
Saved in:
Published in: | Medicinal chemistry research 2020-07, Vol.29 (7), p.1247-1263 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373 |
---|---|
cites | cdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373 |
container_end_page | 1263 |
container_issue | 7 |
container_start_page | 1247 |
container_title | Medicinal chemistry research |
container_volume | 29 |
creator | Jin, Jian Wahlang, Banrida Shi, Hongxue Hardesty, Josiah E. Falkner, K. Cameron Head, Kimberly Z. Srivastava, Sudhir Merchant, Michael L. Rai, Shesh N. Cave, Matthew C. Prough, Russell A. |
description | Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression. |
doi_str_mv | 10.1007/s00044-020-02581-w |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7440142</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2417799659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</originalsourceid><addsrcrecordid>eNp9UctuFDEQtBARCYEf4IAscXbwcx4XJNgQiBQJDnC2vHbProN3vNiehPkOfjgmE5Jw4dDqbndVtVuF0CtGTxil7dtMKZWSUE5rqI6R6yfoiCklScc4fVprWmuuuDhEz3O-pFS0VKpn6FDwTjAl2BH6ferjLz-S4H8ANqPDYxyJe_T2dfUhY-eHARKMxZsQZpxgMwVTAJct4C3sTfEW71MsEHeLyi5Wylx5UIgf3WThVtkEG7cxVPRgSplx8FeQKiqDyYAz1M6X-QU6GEzI8PIuH6PvZx-_rT6Tiy-fzlfvL4iVrSxkrawSDXVC9Y0V3HLR9bTlxtRO8qETjjV916teDp0zloGgDqQRTWedWYtWHKN3i-5-Wu_A2XpfMkHvk9-ZNOtovP53Mvqt3sQr3UpJmeRV4M2dQIo_J8hFX8Yp1Suz5pK1bd83qq8ovqBsijknGO43MKr_GKkXI3U1Ut8aqa8r6fXjv91T_jpXAWIB5DoaN5Aedv9H9gb4-a18</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417799659</pqid></control><display><type>article</type><title>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</title><source>Springer Link</source><creator>Jin, Jian ; Wahlang, Banrida ; Shi, Hongxue ; Hardesty, Josiah E. ; Falkner, K. Cameron ; Head, Kimberly Z. ; Srivastava, Sudhir ; Merchant, Michael L. ; Rai, Shesh N. ; Cave, Matthew C. ; Prough, Russell A.</creator><creatorcontrib>Jin, Jian ; Wahlang, Banrida ; Shi, Hongxue ; Hardesty, Josiah E. ; Falkner, K. Cameron ; Head, Kimberly Z. ; Srivastava, Sudhir ; Merchant, Michael L. ; Rai, Shesh N. ; Cave, Matthew C. ; Prough, Russell A.</creatorcontrib><description>Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression.</description><identifier>ISSN: 1054-2523</identifier><identifier>EISSN: 1554-8120</identifier><identifier>DOI: 10.1007/s00044-020-02581-w</identifier><identifier>PMID: 32831531</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aromatic compounds ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Bioorganic Chemistry ; Congeners ; Cytoskeleton ; Diet ; Dioxins ; Disruption ; Epigenetics ; Exposure ; Fatty acids ; Fatty liver ; Fibrosis ; Gene expression ; Homeostasis ; Inflammation ; Inorganic Chemistry ; Liver ; Liver diseases ; Medicinal Chemistry ; Original Research ; PCB ; Persistent organic pollutants ; Pharmacology/Toxicology ; Pollutants ; Polychlorinated biphenyls ; Proteomes ; Proteomics</subject><ispartof>Medicinal chemistry research, 2020-07, Vol.29 (7), p.1247-1263</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</citedby><cites>FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</cites><orcidid>0000-0001-8901-8490</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32831531$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jin, Jian</creatorcontrib><creatorcontrib>Wahlang, Banrida</creatorcontrib><creatorcontrib>Shi, Hongxue</creatorcontrib><creatorcontrib>Hardesty, Josiah E.</creatorcontrib><creatorcontrib>Falkner, K. Cameron</creatorcontrib><creatorcontrib>Head, Kimberly Z.</creatorcontrib><creatorcontrib>Srivastava, Sudhir</creatorcontrib><creatorcontrib>Merchant, Michael L.</creatorcontrib><creatorcontrib>Rai, Shesh N.</creatorcontrib><creatorcontrib>Cave, Matthew C.</creatorcontrib><creatorcontrib>Prough, Russell A.</creatorcontrib><title>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</title><title>Medicinal chemistry research</title><addtitle>Med Chem Res</addtitle><addtitle>Med Chem Res</addtitle><description>Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression.</description><subject>Aromatic compounds</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Bioorganic Chemistry</subject><subject>Congeners</subject><subject>Cytoskeleton</subject><subject>Diet</subject><subject>Dioxins</subject><subject>Disruption</subject><subject>Epigenetics</subject><subject>Exposure</subject><subject>Fatty acids</subject><subject>Fatty liver</subject><subject>Fibrosis</subject><subject>Gene expression</subject><subject>Homeostasis</subject><subject>Inflammation</subject><subject>Inorganic Chemistry</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Medicinal Chemistry</subject><subject>Original Research</subject><subject>PCB</subject><subject>Persistent organic pollutants</subject><subject>Pharmacology/Toxicology</subject><subject>Pollutants</subject><subject>Polychlorinated biphenyls</subject><subject>Proteomes</subject><subject>Proteomics</subject><issn>1054-2523</issn><issn>1554-8120</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9UctuFDEQtBARCYEf4IAscXbwcx4XJNgQiBQJDnC2vHbProN3vNiehPkOfjgmE5Jw4dDqbndVtVuF0CtGTxil7dtMKZWSUE5rqI6R6yfoiCklScc4fVprWmuuuDhEz3O-pFS0VKpn6FDwTjAl2BH6ferjLz-S4H8ANqPDYxyJe_T2dfUhY-eHARKMxZsQZpxgMwVTAJct4C3sTfEW71MsEHeLyi5Wylx5UIgf3WThVtkEG7cxVPRgSplx8FeQKiqDyYAz1M6X-QU6GEzI8PIuH6PvZx-_rT6Tiy-fzlfvL4iVrSxkrawSDXVC9Y0V3HLR9bTlxtRO8qETjjV916teDp0zloGgDqQRTWedWYtWHKN3i-5-Wu_A2XpfMkHvk9-ZNOtovP53Mvqt3sQr3UpJmeRV4M2dQIo_J8hFX8Yp1Suz5pK1bd83qq8ovqBsijknGO43MKr_GKkXI3U1Ut8aqa8r6fXjv91T_jpXAWIB5DoaN5Aedv9H9gb4-a18</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Jin, Jian</creator><creator>Wahlang, Banrida</creator><creator>Shi, Hongxue</creator><creator>Hardesty, Josiah E.</creator><creator>Falkner, K. Cameron</creator><creator>Head, Kimberly Z.</creator><creator>Srivastava, Sudhir</creator><creator>Merchant, Michael L.</creator><creator>Rai, Shesh N.</creator><creator>Cave, Matthew C.</creator><creator>Prough, Russell A.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8901-8490</orcidid></search><sort><creationdate>20200701</creationdate><title>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</title><author>Jin, Jian ; Wahlang, Banrida ; Shi, Hongxue ; Hardesty, Josiah E. ; Falkner, K. Cameron ; Head, Kimberly Z. ; Srivastava, Sudhir ; Merchant, Michael L. ; Rai, Shesh N. ; Cave, Matthew C. ; Prough, Russell A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aromatic compounds</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Bioorganic Chemistry</topic><topic>Congeners</topic><topic>Cytoskeleton</topic><topic>Diet</topic><topic>Dioxins</topic><topic>Disruption</topic><topic>Epigenetics</topic><topic>Exposure</topic><topic>Fatty acids</topic><topic>Fatty liver</topic><topic>Fibrosis</topic><topic>Gene expression</topic><topic>Homeostasis</topic><topic>Inflammation</topic><topic>Inorganic Chemistry</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Medicinal Chemistry</topic><topic>Original Research</topic><topic>PCB</topic><topic>Persistent organic pollutants</topic><topic>Pharmacology/Toxicology</topic><topic>Pollutants</topic><topic>Polychlorinated biphenyls</topic><topic>Proteomes</topic><topic>Proteomics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jin, Jian</creatorcontrib><creatorcontrib>Wahlang, Banrida</creatorcontrib><creatorcontrib>Shi, Hongxue</creatorcontrib><creatorcontrib>Hardesty, Josiah E.</creatorcontrib><creatorcontrib>Falkner, K. Cameron</creatorcontrib><creatorcontrib>Head, Kimberly Z.</creatorcontrib><creatorcontrib>Srivastava, Sudhir</creatorcontrib><creatorcontrib>Merchant, Michael L.</creatorcontrib><creatorcontrib>Rai, Shesh N.</creatorcontrib><creatorcontrib>Cave, Matthew C.</creatorcontrib><creatorcontrib>Prough, Russell A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicinal chemistry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jin, Jian</au><au>Wahlang, Banrida</au><au>Shi, Hongxue</au><au>Hardesty, Josiah E.</au><au>Falkner, K. Cameron</au><au>Head, Kimberly Z.</au><au>Srivastava, Sudhir</au><au>Merchant, Michael L.</au><au>Rai, Shesh N.</au><au>Cave, Matthew C.</au><au>Prough, Russell A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity</atitle><jtitle>Medicinal chemistry research</jtitle><stitle>Med Chem Res</stitle><addtitle>Med Chem Res</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>29</volume><issue>7</issue><spage>1247</spage><epage>1263</epage><pages>1247-1263</pages><issn>1054-2523</issn><eissn>1554-8120</eissn><abstract>Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with metabolic disruption and nonalcoholic fatty liver disease (NAFLD). Based on their ability to activate the aryl hydrocarbon receptor (AhR), PCBs are subdivided into two classes: dioxin-like (DL) and non-dioxin-like (NDL) PCBs. Previously, we demonstrated that NDL PCBs compromised the liver to promote more severe diet-induced NAFLD. Here, the hepatic effects and potential mechanisms (by untargeted liver proteomics) of DL PCBs and NDL PCBs or co-exposure to both in diet-induced NAFLD are investigated. Male C57Bl/6 mice were fed a 42% fat diet and exposed to vehicle control; Aroclor1260 (20 mg/kg, NDL PCB mixture); PCB126 (20 μg/kg, DL PCB congener); or a mixture of Aroclor1260 (20 mg/kg) + PCB126 (20 μg/kg) for 12 weeks. Each exposure was associated with a distinct hepatic proteome. Phenotypic and proteomic analyses revealed increased hepatic inflammation and phosphoprotein signaling disruption by Aroclor1260. PCB126 decreased hepatic inflammation and fibrosis at the molecular level; while altering cytoskeletal remodeling, metal homeostasis, and intermediary/xenobiotic metabolism. PCB126 attenuated Aroclor1260-induced hepatic inflammation but increased hepatic free fatty acids in the co-exposure group. Aroclor1260 + PCB126 exposure was strongly associated with multiple epigenetic processes, and these could potentially explain the observed nonadditive effects of the exposures on the hepatic proteome. Taken together, the results demonstrated that PCB exposures differentially regulated the hepatic proteome and the histologic severity of diet-induced NAFLD. Future research is warranted to determine the AhR-dependence of the observed effects including metal homeostasis and the epigenetic regulation of gene expression.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32831531</pmid><doi>10.1007/s00044-020-02581-w</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0001-8901-8490</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1054-2523 |
ispartof | Medicinal chemistry research, 2020-07, Vol.29 (7), p.1247-1263 |
issn | 1054-2523 1554-8120 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7440142 |
source | Springer Link |
subjects | Aromatic compounds Biochemistry Biomedical and Life Sciences Biomedicine Bioorganic Chemistry Congeners Cytoskeleton Diet Dioxins Disruption Epigenetics Exposure Fatty acids Fatty liver Fibrosis Gene expression Homeostasis Inflammation Inorganic Chemistry Liver Liver diseases Medicinal Chemistry Original Research PCB Persistent organic pollutants Pharmacology/Toxicology Pollutants Polychlorinated biphenyls Proteomes Proteomics |
title | Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A50%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dioxin-like%20and%20non-dioxin-like%20PCBs%20differentially%20regulate%20the%20hepatic%20proteome%20and%20modify%20diet-induced%20nonalcoholic%20fatty%20liver%20disease%20severity&rft.jtitle=Medicinal%20chemistry%20research&rft.au=Jin,%20Jian&rft.date=2020-07-01&rft.volume=29&rft.issue=7&rft.spage=1247&rft.epage=1263&rft.pages=1247-1263&rft.issn=1054-2523&rft.eissn=1554-8120&rft_id=info:doi/10.1007/s00044-020-02581-w&rft_dat=%3Cproquest_pubme%3E2417799659%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-b5c5360d3596c32c2389072aa6c342f83d16989594f8dac1e30de4a368cdab373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2417799659&rft_id=info:pmid/32831531&rfr_iscdi=true |